PMID: 9420051Jan 7, 1998Paper

Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium

Antimicrobial Agents and Chemotherapy
F CaronG M Eliopoulos

Abstract

RP 59500, a mixture of two semisynthetic streptogramin antibiotics (quinupristin and dalfopristin), is one of a few investigational agents currently in clinical trials with inhibitory activity against multiple-drug-resistant strains of Enterococcus faecium. We evaluated the bactericidal activity of this antimicrobial against 30 recent clinical isolates of vancomycin-resistant E. faecium, including 23 erythromycin-resistant (MIC, >256 microg/ml) and 7 erythromycin-intermediate (MIC, 2 to 4 microg/ml) strains. All isolates were inhibited by RP 59500 at 0.25 to 1.0 microg/ml. The bactericidal activity of RP 59500 was markedly influenced by the erythromycin susceptibility of the strains and by several technical factors, such as inoculum growth phase and time of incubation of counting plates. As determined by time-kill methods, RP 59500 at a concentration of 2 or 8 microg/ml failed to kill erythromycin-resistant organisms under any conditions. Bactericidal activity was observed against all seven erythromycin-intermediate isolates when log-phase inocula were used and the cells were counted after 48 h of incubation (mean reductions in viable bacteria for RP 59500 at concentrations of 2 and 8 microg/ml, 3.45 and 3.50 log10 CFU/ml, resp...Continue Reading

References

Jul 1, 1992·The Journal of Antimicrobial Chemotherapy·A NougayredeD H Bouanchaud
Jul 1, 1992·The Journal of Antimicrobial Chemotherapy·S D EtienneJ J Garaud
Jul 1, 1992·The Journal of Antimicrobial Chemotherapy·A FremauxP Geslin
Jul 1, 1992·The Journal of Antimicrobial Chemotherapy·S GotoY Kaneko
Jul 1, 1992·The Journal of Antimicrobial Chemotherapy·W BrumfittS Shah
Jul 1, 1992·The Journal of Antimicrobial Chemotherapy·C J SoussyA Thabaut
Jul 1, 1992·The Journal of Antimicrobial Chemotherapy·M AumercierF Le Goffic
Feb 1, 1990·Antimicrobial Agents and Chemotherapy·S HandwergerA Kolokathis
Nov 1, 1980·Antimicrobial Agents and Chemotherapy·R D PearsonS W Chapman
Jan 1, 1995·Diagnostic Microbiology and Infectious Disease·C FreemanC Nightingale
Oct 1, 1993·Antimicrobial Agents and Chemotherapy·R Rende-FournierP Courvalin
May 1, 1997·The Journal of Antimicrobial Chemotherapy·D H Bouanchaud
May 1, 1997·The Journal of Antimicrobial Chemotherapy·J D WilliamsA M Sefton

❮ Previous
Next ❯

Citations

Feb 7, 2004·Biotechnology Progress·Sridhar ViamajalaJames N Petersen
Aug 21, 2002·Expert Opinion on Pharmacotherapy·Joseph M Blondeau, Stephen E Sanche
Mar 9, 2000·The New England Journal of Medicine·B E Murray
May 20, 2006·Scandinavian Journal of Infectious Diseases·N KvirikadzeK Singh
Feb 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George M Eliopoulos
Nov 30, 2000·Current Infectious Disease Reports·M E Levison, S Mallela
Apr 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D E LowR N Jones
Feb 6, 2009·Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology·Yukio OkuKoji Yokoyama
Nov 18, 2003·Transplant Infectious Disease : an Official Journal of the Transplantation Society·J A Fishman
Sep 15, 1999·Antimicrobial Agents and Chemotherapy·L SchlegelP Geslin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.